CompletedInterventional · Not applicableNCT05385952 ↗A Prospective, Multicenter, Randomized Clinical Investigation Evaluating the Safety and Efficacy of GATT-Patch Versus TachoSil for Hemostasis During Open Liver SurgeryBenjamin SamsteinPIInterventionDevice: GATT-Patch (currently named ETHIZIA) · Drug: TachoSilDatesAug 2022 – May 2024· Results postedSponsorGATT Technologies B.V.Intraoperative BleedingHemorrhage, SurgicalLiver Diseases
CompletedInterventional · Not applicableNCT05900037 ↗A Prospective, Multicenter, Randomized Clinical Investigation Evaluating GATT-Patch for Hemostasis During Minimally Invasive Liver and Gallbladder SurgeryBenjamin SamsteinPIInterventionDevice: GATT-Patch · Device: SURGICEL® OriginalDatesOct 2023 – Jul 2025SponsorGATT Technologies B.V.Intraoperative BleedingLiver DiseasesGallbladder Diseases+1 more
CompletedInterventional · Not applicableNCT06664788 ↗A Prospective, Multicenter, Randomized Clinical Investigation Evaluating the Safety and Efficacy of ETHIZIA™ Versus SURGICEL® Original in Controlling Minimal, Mild, or Moderate Soft Tissue Bleeding During Open Abdominal, Retroperitoneal, Pelvic, Thoracic (Non-cardiac) and Extremity SurgeryBenjamin SamsteinPIInterventionDevice: ETHIZIA · Device: SURGICEL OriginalDatesApr 2025 – Sep 2026SponsorEthicon INCHemostasisHemostatic Techniques